Month: October 2021

Demand for Rare Neurodegenerative Disease Treatment Market to Reach US$ 116 Bn by 2030

Post author By administrator
Post date October 15, 2021
No Comments on Demand for Rare Neurodegenerative Disease Treatment Market to Reach US$ 116 Bn by 2030

The global rare neurodegenerative disease treatment market is projected to witness steady growth at a CAGR of 5%, reaching a valuation of over US$ 116 billion by 2030. However, the coronavirus outbreak is expected to have a marginally negative impact on the industry in the short term. Supply chain issues and dedication of healthcare facilities towards handling the unprecedented challenges of the pandemic are hindering market growth at present.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5197

On the other hand, increasing investments by market players towards drug development for the treatment of neurodegenerative diseases, and rising awareness among patients about varied treatment options, are major contributors to the growth of the market. Also, rise in medical tourism and investments towards modernization of healthcare infrastructure across developing countries in Asia Pacific are expected to benefit the rare neurodegenerative disease treatment market in the long term.

Key Takeaways from Rare Neurodegenerative Disease Treatment Market Study

North America is a prominent regional market, accounting for a major market share on the back of high healthcare expenditure and the presence of top pharmaceutical manufacturers in the region.
Hospital pharmacies are the leading channel of distribution for drugs associated with neurodegenerative diseases, driven by larger inventories.
Multiple sclerosis is the leading indication in the rare neurodegenerative disease treatment market, supported by growing awareness about the disease and rise in cases in recent years.
Sales of neuroprotective agents are essential for market revenue, with popularity supported by reduced side effects.
The COVID-19 pandemic is expected to have a moderate adverse impact on the global rare neurodegenerative disease treatment market in the short term.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5197

“Lack of awareness about neurodegenerative disease treatments among populations in rural and developing regions and dearth of curative treatment options as compared to disease management offerings are challenges that players in the market will have to contend with,” says a Fact.MR analyst.

Key Segments of Rare Neurodegenerative Disease Treatment Market

Fact.MR’s study on the rare neurodegenerative disease treatment market offers information divided into four important segments — indication, drug class, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Indication	Drug Class	Distribution Channel	Region
Multiple Sclerosis Alzheimer’s Disease Parkinson’s Disease Acute Migraine Autism Narcolepsy Amyotrophic Lateral Sclerosis (ALS) Attention Deficit Hyperactivity Disorder (ADHD) Spinal Muscular Atrophy Tourette Syndrome Huntington’s Disease Others	Neurotransmitter Agents Neuroprotective Agents Biologics Others	Hospital Pharmacies Online Pharmacies Retail Pharmacies	North America Latin America Europe Asia Pacific Middle East & Africa

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/5197

Research on Product Development – Key to Market Growth

Leading players in the global rare neurodegenerative disease treatment market, such as Allergan plc, Bayer AG, GlaxoSmithKline, Johnson & Jonson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. are increasingly investing in capacity and geographical expansion and research into product development pertaining to neurodegenerative ailments. These are key factors that are likely to contribute to the growth of revenue and bolster product improvement in the competitive rare neurodegenerative disease treatment market landscape in the long term.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Automated Dialysis Concentrated Production Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2280/automated-dialysis-concentrated-production-systems-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Rare Neurodegenerative Disease Treatment Market, Rare Neurodegenerative Disease Treatment Market Analysis, Rare Neurodegenerative Disease Treatment Market Demand, Rare Neurodegenerative Disease Treatment Market Estimate, Rare Neurodegenerative Disease Treatment Market Forecast, Rare Neurodegenerative Disease Treatment Market Insights, Rare Neurodegenerative Disease Treatment Market Scope, Rare Neurodegenerative Disease Treatment Market Share, Rare Neurodegenerative Disease Treatment Market Size, Rare Neurodegenerative Disease Treatment Market Statistics, Rare Neurodegenerative Disease Treatment Market Trends

Pharmaceutical

Demand for Medical Gases and Equipment Market to Grow at Over 8% CAGR Through 2030

Post author By administrator
Post date October 15, 2021
No Comments on Demand for Medical Gases and Equipment Market to Grow at Over 8% CAGR Through 2030

The global medical gases and equipment market is exhibiting steady growth with the surge in demand from hospitals, home care settings, pharmaceutical companies, and other healthcare facilities. A recent study by Fact.MR states that the medical gases and equipment market is anticipated to grow at over 8% CAGR during the forecast period between 2020 and 2030.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5428

Rising cases of chronic ailments such as diabetes, cancer, asthma, cardiovascular and respiratory diseases, and communicable diseases have been creating scope for expansion. According to the Centers for Disease Control and Prevention, one out of two adults in the U.S. suffer from chronic diseases.

Data obtained from same source revealed that 86% of national expenditure, accounting for US$ 2.7 trillion, were incurred on the treatment of mental health conditions and chronic ailments in the U.S. These facts and figures indicate the surge in incidence of chronic ailments, which is expected to fuel the demand for medical gases and equipment in the coming years.

Though the outbreak of COVID-19 pandemic has impacted production process across manufacturing units in the first half of this year, the market is forecast to recover soon owing to the rush of patients across healthcare facilities.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5428

Key Takeaways from Medical Gases and Equipment Market Report

The increase in therapeutic application of medical gases and equipment is forecast to fuel the sales through the forecast period
Hospitals will continue exhibiting surging demand in the coming years
North America will dominate in the global medical gases and equipment market, with the U.S at the forefront. The demand from East Asia too is expected to rise in the coming years
With the on-set of COVID-19 pandemic, the market has been experiencing surge in demand which tends to persist over the next couple of years

Medical Gases and Equipment Market – Segmentation

Application

Therapeutic
Pharmaceutical Manufacturing & Research
Diagnostic
Other Applications

End User

Hospitals
Home Care Settings
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Emergency Services

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/5428

Some of the companies profiled in the medical gases and equipment market report are Airgas Inc., Atlas Copco AB, GCE Group AB, Matheson Tri-Gas Inc., Messer Group GmbH, and Praxair Inc.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Percussion Vests Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5263/percussion-vests-market

Continuous Cardiac Monitoring Systems Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5265/continuous-cardiac-monitoring-systems-market

Handheld Fluorescence Imaging Devices Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030 – https://www.factmr.com/report/5266/handheld-fluorescence-imaging-devices-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Medical Gases and Equipment Market, Medical Gases and Equipment Market Analysis, Medical Gases and Equipment Market Demand, Medical Gases and Equipment Market Estimate, Medical Gases and Equipment Market forecast, Medical Gases and Equipment Market insights, Medical Gases and Equipment Market Scope, Medical Gases and Equipment Market Share, Medical Gases and Equipment Market size, Medical Gases and Equipment Market Statistics, Medical Gases and Equipment Market Trends

Pharmaceutical

Global Microscopy Devices Market to Grow at a CAGR of 8.5% Through 2025

Post author By administrator
Post date October 15, 2021
No Comments on Global Microscopy Devices Market to Grow at a CAGR of 8.5% Through 2025

The usage of microscopy devices has registered an uptick in the past few years. Microscopes have allowed in-depth academic and exploratory research in various branches of science. Amongst the wide range of sciences, the life sciences division has found increased usage of microscopy devices, particularly in cell biology. Also, the need for more penetrative media to identify cells has boosted technological developments in microscopic devices. On the back of these trends, the global microscopy devices market is poised to expand 1.6x, registering a CAGR of 8.5% throughout the forecast period (2020-2025).

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4796

Nowadays, major life science companies are increasingly seeking the services of contract research organizations (CROs) to reduce their overall expenditure and concentrate on their core businesses. This has enabled several microscopy service providers to invest in research and development of microscopes. The ongoing coronavirus pandemic is anticipated to leverage market prospects. With the number of infections climbing at an exponential rate, hospitals and other healthcare settings have experienced an uptick in the number of diagnostic tests to determine the presence of the virus. On the back of this, the usage of microscopes to detect potential pathogens has increased. Leading players are therefore concentrating on streamlining their production processes to cater to this increased demand.

Key Takeaways of Global Microscopy Devices Market Study:

Optical microscopes are projected to account for a major chunk of the market, capturing more than three-fifths of the market share. Rising demand for different types of optical microscopes such as fluorescence and inverted microscopes and low cost of stereo and phase contrast microscopes shall drive the segment’s growth.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4796

By application, Cell and Molecular Biology and Biomedical engineering are anticipated to make exhaustive utilization of microscopy devices. This is due to increased adoption of microscopes in microbiology, cell culture, healthcare monitoring and launch of new therapeutic products. Projected CAGR for both segments is pegged at 8.3%.
Clinical Pathology and Diagnostics shall find equally important microscopy applications, for understanding pathological changes in conditions such as Alzheimer’s and Parkinson’s diseases and chronic diseases. Anticipated CAGR for this segment is a staggering 8.2%.
By end-users, diagnostic laboratories are anticipated to find maximum usage of microscopy devices. The need to accurately identify potentially life-threatening diseases such as tuberculosis and immunological ailments such as HIV-AIDS and diabetes in order to suggest appropriate corrective course of action is anticipated to drive the segment’s growth.
Asia-Pacific is projected to emerge as the leader of the global microscopy devices market, capturing more than half of the total market share. An emerging pharmaceutical industry, liberalization and deregulation of key markets and rising adoption of electron and scanning probe microscopes shall drive the Asia-Pacific regional growth.
However, North America is projected to soar in popularity due to increased patent filing approvals, increased government funding for life sciences projects, greater flexibility in regulations and high transparency. Besides, adoption of optical microscopes is poised to increase during the forecast period. The region is set to expand 1.6x, capturing nearly one-fourth of the global microscopy devices market.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4796

“The global microscopy devices market is poised to experience a healthy growth trajectory. Rising incentives for research in life sciences in the form of government funding, relaxation of regulations and growing healthcare infrastructure are anticipated to leverage the prospects of microscopy devices,” concludes a Fact.MR analyst.

Technological Developments to Boost Key Players’ Market Prospects:

The global microscopy devices market consists of the following key market players: Olympus Corporation, JOEL Ltd., Nikon Corporation, Carl Zeiss Microscopy GmBh, FEI Company, Leica Microsystems, Hitachi High-Technologies Corporation, Bruker Corporation and CAMECA SAS. Most of these market players rely on technological advancements to increase market presence.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Microscopy Devices Market, Microscopy Devices Market Analysis, Microscopy Devices Market Demand, Microscopy Devices Market Estimate, Microscopy Devices Market Forecast, Microscopy Devices Market Insights, Microscopy Devices Market Scope, Microscopy Devices Market Share, Microscopy Devices Market Size, Microscopy Devices Market Statistics, Microscopy Devices Market Trends

Pharmaceutical

What are Key Growth Influencers of the Controlled Substances Market

Post author By administrator
Post date October 15, 2021
No Comments on What are Key Growth Influencers of the Controlled Substances Market

Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in 2018, and are projected to record a Y-o-Y growth at 3.5% in 2019, according to a new Fact.MR study. The study opines that depressants and stimulants have been top-selling class of drugs in the controlled substances market, however gains from marijuana are expected to record over 2X faster growth than all the other controlled substances in 2019 and beyond.

Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently. This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest. The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=2032

“The Schedule of Controlled Substances currently positions marijuana in Schedule 1 – the most restrictive one reserved for “high potential for abuse,” “lack of accepted safety” and “no accepted medical use” drugs. Federal scheduling of marijuana has been a key concern among producers and medical patients alike, despite legalization of cannabis in the US and Canada. The US Drug Enforcement Administration has recently removed cannabidiol from Schedule 1, post-FDA approval of non-synthetic, cannabis-derived medicine. Marijuana businesses have cheered the DEA’s action, as it alludes the beginning of regulatory relaxation to the cannabis industry,” according to a lead analyst at Fact.MR.

Pain Management Remains Leading Application of Controlled Substances

The study opines that pain management will continue to account for over one-fourth share of the controlled substances market in 2018. Several regulatory norms being implemented in the prescription of controlled substances for pain management, such as in Georgia, Michigan, and Florida, have further triggered the preference and adoption of controlled substances to manage and treat chronic as well as acute pain. Attention deficit hyperactivity disorder (ADHD), and anxiety are other medical conditions wherein controlled substances are expected to witness promising future prospects, according to the study.

For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=2032

The entrance of pharmaceutical giants in the cannabis sector of Canada alludes the next significant trend in the controlled substances industry, offering additional credibility to the sector. Although the pharmaceutical part of the expression involves the missing link, an ongoing trend of M&A and entrance of these legacy industries is poised in 2019 and the foreseeable future. There has been a drought in direct investments from the pharmaceutical industries in the licensed medical marijuana producers, it is highly likely that the trend would change, as the US witnesses the federal legalization of cannabis. Big pharmaceutical companies that eye collaborations and partnerships with cannabis producers having competitive differentiation circling their R&D initiatives, commercialization efforts, and clinical trial programs, are likely to witness significant revenue generation in the near future.

Ensuring effective and safe management of controlled drugs continues to remain an imperative agenda among pharmacists, which in turn has led the focus on fundamental changes including reviewing of liquid CD management and CD documentation to realize substantial improvements. The pharmacists are also adhering to the operational standards, completely aware about the way CDs are managed, along with identifying potential drawbacks and reporting concerns regarding non-conformance. This will result in adherence to appropriate steps that ensure apt prescription of quantities when dispensing controlled substances to patients.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/2032

This Fact.MR report also offers an accurate forecast of the controlled substances market for the period between 2018 and 2028. The controlled substances market is envisaged to record a CAGR of 4% through 2028

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Controlled Substances Market, Controlled Substances Market Analysis, Controlled Substances Market Demand, Controlled Substances Market Estimate, Controlled Substances Market Forecast, Controlled Substances Market Insights, Controlled Substances Market Scope, Controlled Substances Market Share, Controlled Substances Market Size, Controlled Substances Market Statistics, Controlled Substances Market Trends

Pharmaceutical

What is the Role of Advanced R&D in Widening Lithotripsy Devices Demand

Post author By administrator
Post date October 15, 2021
No Comments on What is the Role of Advanced R&D in Widening Lithotripsy Devices Demand

The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the lithotripsy devices market is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most preferred way of treating kidney stones, owing to myriad advantages of lithotripsy devices, such as low cost, relative safety, negligible recovery time and positive results.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=3084

The Fact.MR report on lithotripsy devices market opines that the growing adoption of lithotripsy devices owing to their ability to treat all kinds of kidney stones with impressive success rates for ureteral stones without any considerable complications has been underpinning gains in lithotripsy devices market.

Surging Incidence of Urolithiasis to Boost Sales of Lithotripsy Devices

Urolithiasis is a widely prevalent urologic issue, which constitutes considerable burden on the healthcare system across the globe. According to Fact.MR report on lithotripsy devices market, apart from widespread prevalence, urolithiasis has been linked to an increased risk of end-stage renal failure, which has further accelerated the demand for lithotripsy devices. As per the U.S. National Institutes of Health, urolithiasis affects roughly 12% of the worldwide population once in lifetime. The report opines that the growing prevalence of kidney stones is likely to drive the growth of lithotripsy devices market during the forecast period.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=3084

The rapidly advancing technology and manifold extracorporeal shock wave lithotripsy procedures are anticipated to act as a main growth driver for lithotripsy devices market, as per Fact.MR study. Further, lithotripsy devices’ manufacturers are focusing on creating novel and cutting-edge lithotripsy devices, which is expected to fuel growth in global lithotripsy devices market during 2018-2026.

The Fact.MR report on lithotripsy devices opines that lithotripsy procedures are likely to become an outpatient procedure in the forthcoming years, witnessing a robust growth in ambulatory surgical center segment by end users. Though there are newer ways for the treatment of kidney stones, patients are increasingly opting for minimally invasive or non-invasive treatment as a viable method for kidney stones treatment.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/3084

Furthermore, as modern day lithotripters provide a wide range of settings to clinicians, medical practitioners get the liberty to adopt diverse combinations with various effects during the procedure. However, the prevalence of substitutes for kidney stones treatment is likely to dampen the growth of lithotripsy market during the foreseeable period. Additionally, adverse effects linked to the use lithotripsy, such as internal bleeding is another key factor likely to dampen the growth of lithotripsy devices market.

Europe to Dominate Lithotripsy Devices Market with Prevalence of Key Market Players

According to Fact.MR analysis of lithotripsy devices market, Europe is envisaged to dominate lithotripsy devices market and is projected to reach US$ 307.5 MN by the end of foreseeable period due to the presence of leading market players in the region.

Europe will be closely trialed by Asia-Pacific excluding China (APEC) lithotripsy devices market. APEC lithotripsy devices market is likely to account for second largest value share in lithotripsy devices market due to increasing burden of chronic diseases in tandem with the developing healthcare infrastructure in the region, apart from the growing initiatives to promote adoption of lithotripsy devices.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Bartter Syndrome Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2192/bartter-syndrome-treatment-market

Antibacterial Washcloth Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2190/antibacterial-washcloth-market

Acromegaly Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2191/acromegaly-treatment-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Lithotripsy Devices Market, Lithotripsy Devices Market Analysis, Lithotripsy Devices Market Demand, Lithotripsy Devices Market Estimate, Lithotripsy Devices Market Forecast, Lithotripsy Devices Market Insights, Lithotripsy Devices Market Scope, Lithotripsy Devices Market Share, Lithotripsy Devices Market Size, Lithotripsy Devices Market Statistics, Lithotripsy Devices Market Trends

Pharmaceutical

Biologics Drugs and PDE4 Inhibitors to Account for Major Chunk of Atopic Dermatitis Market Share Through 2027

Post author By administrator
Post date October 15, 2021
No Comments on Biologics Drugs and PDE4 Inhibitors to Account for Major Chunk of Atopic Dermatitis Market Share Through 2027

Dermatological disorders are increasing with each passing day. The World Health Organization estimates that more than 900 million people are suffering from skin ailments since 2017. Atopic dermatitis accounts for a major chunk of these illnesses, with more than 300 million people, mostly children, affected by it. Based on the aforementioned trends, the global atopic dermatitis drugs is expected to register astounding growth of 24% between 2020 and 2027.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

Research and development in manufacturing novel drugs, rising demand for biologics and product approvals are other factors augmenting market growth. On this premise, the atopic dermatitis market is poised to surpass a valuation of US$ 19 Bn by the end of the forecast period.

Key Takeaways of Global Atopic Dermatitis Drugs Market Study

Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603

Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.
North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

Drug Class	Corticosteroids PDE4 Inhibitors Biologics Skin Barrier Emollients CNI Immunosuppressants Others
Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Key Regions	North America Europe Asia Pacific Latin America Middle East & Africa

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4603

Development of Novel Drugs to Determine Market Competitiveness

Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Atopic Dermatitis Market, Atopic Dermatitis Market Analysis, Atopic Dermatitis Market Demand, Atopic Dermatitis Market Estimate, Atopic Dermatitis Market Forecast, Atopic Dermatitis Market Insights, Atopic Dermatitis Market Scope, Atopic Dermatitis Market Share, Atopic Dermatitis Market Size, Atopic Dermatitis Market Statistics, Atopic Dermatitis Market Trends

Pharmaceutical

Sales of Beta Lactams to Bring in US$ 500 Million Revenue by 2026 end

Post author By administrator
Post date October 15, 2021
No Comments on Sales of Beta Lactams to Bring in US$ 500 Million Revenue by 2026 end

Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=361

Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.

As per the report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register 3.4% CAGR during the forecast period 2017-2026. The global pharyngitis market is also estimated to reach US$ 1,679.0 million revenue by the end of 2026.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=361

Pharyngitis is the most common problem among people. It is mostly caused due to other illness such as flu, cold, or mononucleosis it results in sore throat. Most of the health providers diagnose pharyngitis with the help of rapid strep test. Medicines are given by doctor only after determining whether the infection is viral or bacterial. Hence, manufacturers of drugs are conducting research to develop more effective drugs to treat pharyngitis. Below are few insights on how the global pharyngitis market will perform in the coming years.

5 Forecast Highlights on Global Pharyngitis Market

Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/361

Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

Market Taxonomy

Drug Class	Beta Lactams Macrolides Cephalosporins Fluoroquinolones Tetracycline Other Products
Distribution Channel	Hospital Pharmacies Retail Pharmacies and Drug Stores Online Pharmacies
Mode of Delivery	Oral Intravenous Intramuscular Other Mode of Delivery

The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Bartter Syndrome Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2192/bartter-syndrome-treatment-market

Antibacterial Washcloth Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2190/antibacterial-washcloth-market

Acromegaly Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2191/acromegaly-treatment-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Pharyngitis Market, Pharyngitis Market Analysis, Pharyngitis Market Demand, Pharyngitis Market Estimate, Pharyngitis Market Forecast, Pharyngitis Market Insights, Pharyngitis Market Scope, Pharyngitis Market Share, Pharyngitis Market Size, Pharyngitis Market Statistics, Pharyngitis Market Trends

Pharmaceutical

Inexpensive Treatments to Make Dental Endodontics Popular in Asia

Post author By administrator
Post date October 15, 2021
No Comments on Inexpensive Treatments to Make Dental Endodontics Popular in Asia

Influence of dental tourism to avail affordable, yet quality dental care, in tandem with rising consciousness regarding oral health and hygiene, signifies promising opportunities for players in the dental endodontics market.

A recent study by Fact.MR further analyses the dental endodontics market in detail, and finds that endodontic motor instruments continue to hold a sizeable market share, given their competency to offer time-efficient root canal procedures that help dentists in achieving high productivity. Market players are moving towards nickel and titanium materials to provide high elasticity to endodontic instruments, thereby complementing the adoption rate.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4436

Despite being conventional, consumables are evolving with advanced technology, and market players are experimenting with various parameters such as design and material to increase convenience for dentists. On the back of growing preference for quicker, safer, and reliable systems, adoption of dental endodontics instruments is projected to remain significantly higher than consumables during the forecast period.

Key Highlights of Dental Endodontics Market Study

A marked shift from 2D imaging systems to 3D cone beam imaging technology, which is gradually transforming the way dentists collect information, serves as a harbinger of significant adoption opportunities for players in the dental endodontics market.
Accuracy and versatility are viable propositions to achieve marketing success; however, the emergence of laser dentistry as an effective substitute for dental endodontics could challenge the otherwise steady adoption rate of endodontic systems.
Dental clinics would retain their status as primary dental care centres, as short-wait times and cost-effective solutions remain key touchpoints for individuals. On the back of this influential growth enabler, demand for dental endodontics from dental clinics is likely to remain 32% higher than dental hospitals.
Density of the geriatric population is significantly high in Japan, which generates high demand for dentistry in the country. Also, technological advancements come to the disposal of players operating in the dental endodontics market. During the forecast period, Japan is likely to register the highest CAGR of around 6.3%.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4436

Important doubts related to the market clarified in the report:

Which regional market is expected to witness the highest growth during the forecast period?
How has the surging prices of raw materials impacted the growth of the market?
Why are market players focusing on R&D and innovations?
Are market players expanding their global presence? If yes, how?
What is the estimated value of the market in 2019?

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4436

Strategic Acquisitions to Remain at Leading Players’ Disposal

Strong geographical presence, strategic acquisitions, and collaborations are key strategies undertaken by players in the dental endodontics market to strengthen their market position. For instance, in 2017 COLTENE Holding AG announced the acquisition of Micro-Mega and SciCan, which are key companies working towards the development of dental equipment and materials, by investing around US$ 200 Mn. In addition, in September 2017, Dentsply Sirona announced the acquisition of Healthdent Technologies Inc. to boast a diversified range of root canal treatment solutions.

Prominent as well as emerging players in the dental endodontics market, however, evince high reliance on product innovation and effective marketing strategies to distinguish their brands and increase brand value.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Dental Endodontics Market, Dental Endodontics Market Analysis, Dental Endodontics Market Demand, Dental Endodontics Market Estimate, Dental Endodontics Market Forecast, Dental Endodontics Market Insights, Dental Endodontics Market Scope, Dental Endodontics Market Share, Dental Endodontics Market Size, Dental Endodontics Market Statistics, Dental Endodontics Market trends

Pharmaceutical

What Scope Do Technological Advancements Have in Furthering Cancer Profiling

Post author By administrator
Post date October 15, 2021
No Comments on What Scope Do Technological Advancements Have in Furthering Cancer Profiling

Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR’s latest study. Growing at a subdued 4% y-o-y, the study foresees absolute opportunity of over US$ 36 million in 2019. Steadily rising opportunities in cancer profiling market can be attributed to,

Increasing disease burden of cancer worldwide
Significant economic burden associated with cancer diagnosis and treatment
Growing R&D investments to develop effective cancer diagnostics
Increasing importance of precision medicine adoption and reliance of cancer profiling

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=358

According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

The study estimates that Europe represents the second most significant demand for cancer profiling and accounts for over four fifth of the global revenues. Rising incidences of cancer, EU’s proactive efforts to promote cancer screening and use of best practices to improve the quality are responsible for the significant investments in cancer profiling space in Europe.

Fact.MR finds that APEJ will register significant utilization of cancer profiling in coming years on the back of rising awareness and adoption of improved tools for cancer identification.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=358

Breast Cancer Accounts for Nearly Half the Cancer Profiling Revenues

According to the study, breast cancer is expected to take maximum advantage of cancer profiling as compared to other cancer types. After lung cancer, breast cancer is the second most leading cause of new cancer cases.

Globally, national governments are actively engaged in generating awareness regarding the prevention and diagnosis of breast cancer. As cancer profiling applications remain higher in breast cancer diagnosis, a significant fall in breast cancer mortality shows promising diagnosis and improved treatment.

Colorectal cancer is also categorized among one of the leading causes of new cancer cases and cancer deaths. The study finds that followed by breast cancer, a significant utilization of cancer profiling can be observed in colorectal cancer.

The Fact.MR report tracks the cancer profiling market for the period 2018-2028. According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.

Chapter 1 – Executive Summary – Global Cancer Profiling Market

The cancer profiling market report commences with the chapter of executive summary. The highlighted numbers in executive summary provides the readers with a quick yet informative look of the cancer profiling market. In addition to market summary, the chapter also covers information such as megatrends and opportunity assessment in the cancer profiling market.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/358

Chapter 2 – Market Overview

In the market overview chapter, the cancer profiling market report provides information on cancer profiling definition and introduction of the cancer profiling market. The chapter also discusses scope of the cancer profiling market report.

Chapter 3 – Market Dynamics

In this chapter of the cancer profiling market report, study of market dynamics in terms of market drivers, restraints, opportunities and trends is provided. The assessment of the cancer profiling market is carried out for the historical period 2013-2017 and forecast period 2018-2028. The chapter also covers economic factors that influence the product demand, forecast factors and their impact analysis.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Percussion Vests Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5263/percussion-vests-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags cancer profiling market, Cancer Profiling Market Analysis, Cancer Profiling Market Demand, Cancer Profiling Market Estimate, Cancer Profiling Market Forecast, Cancer Profiling Market Insights, Cancer Profiling Market Scope, Cancer Profiling Market Share, Cancer Profiling Market Size, Cancer Profiling Market Statistics, Cancer Profiling Market Trends

Pharmaceutical

Sales of Fibrosarcoma Market to Reach US$ 442.4 Million Revenue by 2026 end

Post author By administrator
Post date October 15, 2021
No Comments on Sales of Fibrosarcoma Market to Reach US$ 442.4 Million Revenue by 2026 end

Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no exact cause but carries various risk factors. Undergoing as radiotherapy to treat other cancer is one of the factors that is increasing the risk of fibrosarcoma. Currently, there are very few ways to treat fibrosarcoma with complications involved.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=353

Hence, researchers and research institutes around the world are researching for some very effective treatments. Targeted therapies are also being focused on to treat fibrosarcoma. There are also many anti-angiogenesis agents under development and few are in clinical trials. Chemotherapy for soft tissue sarcoma usually involves a combination of various drugs. Hence, companies are researching on new drugs effective in treating soft tissue sarcoma.

According to a study by Fact.MR, the global fibrosarcoma market is expected to witness steady growth. The market is likely to register CAGR of 5.5% during the forecast period 2017-2026. The global fibrosarcoma market is also projected to bring in US$ 442.4 million revenue.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=353

Fibrosarcoma is increasingly rare as a diagnosis compared to other sarcoma subtypes. Some of the sarcomas are sensitive to chemotherapy, hence ongoing attempts are being done to intensify chemotherapy. However, fibrosarcoma that does not respond to chemotherapy, needs to be treated with other methods but might lead to some side-effects. This is driving the development of new therapies with potential benefits. Below insights show how the global fibrosarcoma market will perform in the coming years.

5 Forecast Highlights on Global Fibrosarcoma Market

North America is expected to remain dominant in the global fibrosarcoma market during the forecast period 2017-2026. Well-developed healthcare infrastructure in North America is one of the factors boosting the growth of fibrosarcoma treatment in the region. Technological advancement is also resulting in the development of advanced cancer treatment drugs. Moreover, increasing population suffering from diabetes, overweight and depression are also leading towards high possibilities of cancer.
Europe and Asia Pacific Excluding Japan (APEJ) are also expected to witness growth in the diagnoses and treatment of fibrosarcoma due to the increasing investments in the research and development activities for treatment of various cancers.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/353

Chemotherapy is expected to be the most preferred treatment for fibrosarcoma. By the end of 2026, chemotherapy is projected to reach close to US$ 200 million revenue.
Hospitals are expected to be the largest end-users in the global fibrosarcoma market. Hospitals are projected to reach nearly US$ 200 million revenue by the end of 2026.
Among various distribution channels, hospital pharmacy is expected to emerge as the largest distribution channel during the forecast period 2017-2026. Accounting for nearly half of the revenue share, hospital pharmacies are projected to exceed US$ 100 million revenue towards the end of 2026.

Market Taxonomy

Treatment Type	Chemotherapy Radiation Therapy Surgery Other Therapy
End User	Hospitals Clinics Specialized Cancer Treatment Centers Other End Users
Distribution Channel	Hospital Pharmacy Retail Pharmacy E-Commerce Other Distribution Formats

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=353

The report also offers an in-depth analysis of the leading market players in the global market for fibrosarcoma, which will remain active through 2026. These include companies such as Johnson & Johnson, Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Novartis AG, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Bristol-Myers Squibb Company, Celon Laboratories Limited, and Cadila Pharmaceuticals Limited.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Dermatology Diagnostic Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5453/dermatology-diagnostic-devices-market

Paper Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5454/paper-diagnostics-market

DNA Probes based Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030 : https://www.factmr.com/report/5474/dna-probes-based-diagnostics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Fibrosarcoma Market, Fibrosarcoma Market Analysis, Fibrosarcoma Market Demand, Fibrosarcoma Market Estimate, Fibrosarcoma Market Forecast, Fibrosarcoma Market Insights, Fibrosarcoma Market Scope, Fibrosarcoma Market Share, Fibrosarcoma Market Size, Fibrosarcoma Market Statistics, Fibrosarcoma Market Trends